Effects of Rolipram on Spinal Cord Transection Injury in Rats

LI Feng-tao,CHENG Bin,LI Hao-peng
DOI: https://doi.org/10.3969/j.issn.1006-9771.2013.07.009
2013-01-01
Abstract:Objective To investigate the possibility of rolipram for treatment of spinal cord injury(SCI) in rats.Methods 30 adult female Sprague-Dawley rats were divided into sham-operation group(sham group,n=10),spinal cord injury group(SCI group,n=10) and rolipram treatment group(R group,n=10).The rats in SCI group and R group were modeled as spinal cord transection injury,and R group was administrated with rolipram subcutaneouly after SCI.They were assessed with Basso Beattie and Bresnahan(BBB) score 2,4,6,and 8 weeks after SCI,and the expressions of growth associated protein 43(GAP-43) and glial fibrillary acidic protein(GFAP) were detected with immunohistochemistry 2 weeks after SCI.Results There were significant difference in the BBB scores between SCI and R groups 6 and 8 weeks after SCI(P<0.05).The expression of GAP-43 was more and GFAP was less in R group than in SCI group(P<0.05).Conclusion Rolipram can increase the expression of GAP-43 and inhibit the expression of GFAP,while improves the the motor function in rats after spinal cord transsection injury.
What problem does this paper attempt to address?